TIM
OGN icon

Tevis Investment Management’s Organon & Co OGN Stock Holding History

Tevis Investment Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-735
Closed -$17K – 158
2022
Q3 		$17K Hold
735
– – 0.02% 300
2022
Q2 		$25K Hold
735
– – 0.02% 255
2022
Q1 		$26K Hold
735
– – 0.02% 267
2021
Q4 		$22K Buy
+735
New +$23.9K 0.02% 315

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Tevis Investment Management's OGN Position: Q4 2022 in Review

Tevis Investment Management sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 735 shares — an estimated $17K sold.

Tevis Investment Management first reported a position in OGN in Q4 2021 and held it in 4 quarters. The position peaked at $26K in Q1 2022. 821 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

  • Tevis Investment Management reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
  • Tevis Investment Management sold 735 Organon & Co shares in Q4 2022, an estimated $17K.
  • Tevis Investment Management first reported a position in Organon & Co in Q4 2021 and held it in 4 quarters.
  • Tevis Investment Management's Organon & Co position peaked at $26K in Q1 2022.
  • 821 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on Tevis Investment Management's 13F filing for Q4 2022, filed 31 Jan 2023.